Porcine intestinal epithelial barrier disruption by the Fusariummycotoxins deoxynivalenol and T-2 toxin promotes transepithelial passage of doxycycline and paromomycin
© Goossens et al.; licensee BioMed Central Ltd. 2012
Received: 16 August 2012
Accepted: 1 December 2012
Published: 17 December 2012
The gastrointestinal tract is the first target for the potentially harmful effects of mycotoxins after intake of mycotoxin contaminated food or feed. With deoxynivalenol (DON), T-2 toxin (T-2), fumonisin B1 (FB1) and zearalenone (ZEA) being important Fusarium toxins in the northern hemisphere, this study aimed to investigate in vitro the toxic effect of these mycotoxins on intestinal porcine epithelial cells derived from the jejunum (IPEC-J2 cells). Viability of IPEC-J2 cells as well as the proportion of apoptotic and necrotic IPEC-J2 cells was determined by flow cytometry after 72 h of exposure to the toxins. Correlatively, the integrity of the intestinal epithelial cell monolayer was studied using Transwell® inserts, in which the trans-epithelial electrical resistance (TEER) and passage of the antibiotics doxycycline and paromomycin were used as endpoints.
We demonstrated that the percentage of Annexin-V-FITC and PI negative (viable) cells, Annexin-V-FITC positive and PI negative (apoptotic) cells and Annexin-V-FITC and PI positive (necrotic) IPEC-J2 cells showed a mycotoxin concentration-dependent relationship with T-2 toxin being the most toxic. Moreover, the ratio between Annexin-V-FITC positive and PI negative cells and Annexin-V-FITC and PI positive cells varied depending on the type of toxin. More Annexin-V-FITC and PI positive cells could be found after treatment with T-2 toxin, while more Annexin-V-FITC positive and PI negative cells were found after exposure to DON. Consistent with the cytotoxicity results, both DON and T-2 decreased TEER and increased cellular permeability to doxycycline and paromomycin in a time- and concentration-dependent manner.
It was concluded that Fusarium mycotoxins may severely disturb the intestinal epithelial barrier and promote passage of antibiotics.
KeywordsMycotoxins Cytotoxicity Flow cytometry Permeability Intestinal cells
Mycotoxins are naturally occurring secondary metabolites produced by fungi. They can be formed in the field on crops as well as during storage and are chemically very stable, enabling them to survive processing, and thereby end up in the feed and food chain. In the northern temperate regions Fusarium species are the most prevalent toxigenic fungi [1, 2] with trichothecenes, fumonisins and zearalenone being the most important toxins produced . If ingested, these mycotoxins can cause a variety of adverse health effects, both on humans and animals . Since the gastrointestinal epithelium is the first barrier to come in contact with mycotoxins after ingestion, several studies investigated the effects of mycotoxins on intestinal cells. Most of these were conducted on human intestinal epithelial Caco-2 cells [5–16], but also the porcine intestinal epithelial cell lines IPEC-1  and IPEC-J2 [18–20] have been used to demonstrate that mycotoxins can alter the integrity of the gut barrier. Moreover, Pinton et al.[12, 13] showed that the trichothecene deoxynivalenol (DON) selectively affects the expression of tight junction proteins in porcine intestinal epithelial cell monolayers (IPEC-1) and Caco-2 cell monolayers resulting in increased paracellular passage of fluorescein isothiocyanate (FITC)-dextran and Escherichia coli. It was also demonstrated that fumonisin B1 (FB1) affects the membrane composition of IPEC-1 cells resulting in an increased passage of this toxin . Intestinal epithelial cells are thus important targets for the toxic effects of mycotoxins and it is clear that an altered barrier could result in an altered passage of mycotoxin co-contaminants, xenobiotics and pathogens.
The aim of the present study was to evaluate the cytotoxic effect of the four most important Fusarium mycotoxins i.e. DON, T-2 toxin (T-2), zearalenone (ZEA) and FB1 in intestinal epithelial cells derived from the jejunum of pigs (IPEC-J2 cells). Therefore the percentage viable, apoptotic and necrotic IPEC-J2 cells was determined using flow cytometry. Correlatively, it was investigated whether differences in cell viability result in a changed transepithelial passage of the antibiotics doxycycline and paromomycin. This was studied using Transwell® devices which are commonly applied and widely accepted to perform permeability studies. The hypothesis tested in this study was that an altered integrity of the gut barrier provoked by mycotoxins, could result in an increased passage of antibiotics through the epithelium. Increased passage of these antibiotics can indeed have toxic consequences for the animal, withdrawal time, and consequently public health with respect to possible residues of drugs in edible tissues. To our knowledge, this is the first time that transport of antibiotics is used as a marker to study possible damage of mycotoxins to intestinal epithelial cells.
Cell line and culture conditions
The IPEC-J2 cell line is a continuous intestinal cell line originally derived from jejunal epithelia isolated from a neonatal, unsuckled piglet and maintained as a continuous culture . Cells were grown in Dulbecco’s Modified Eagle Medium (DMEM)/Ham’s F12 (1:1) medium (Invitrogen™ Life Technologies, Carlsbad, CA, USA), supplemented with 5% fetal calf serum (FCS, HyClone, Cramlington, England, UK), 1% (v/v) insulin/transferrin/Na-selenite (Gibco, Life Technologies, Paisley, Scotland), 1% (v/v) penicillin/streptomycin (Gibco, Life Technologies) and 1% (v/v) kanamycin (Gibco, Life Technologies), further referred to as culture medium. The cells were routinely seeded at a density of 1.5 × 105 cells/ml with 18 ml medium in plastic tissue culture flasks (75 cm2, Nunc, Denmark), maintained in a humidified incubator at 37°C under 5% CO2, and passaged every 2–3 days. All experiments were performed with cells within maximal 10 passages.
DON, T-2, FB1 and ZEA (Sigma-Aldrich, Bornem, Belgium) stock solutions of 2000 μg/ml were prepared in methanol for DON, ethanol for T-2 and acetonitrile for FB1 and ZEA (Merck, Darmstadt, Germany). Doxycycline and paromomycin stock solutions (Sigma-Aldrich, 2000 μg/ml) were prepared in high-performance liquid chromatography (HPLC) grade water. All stock solutions were stored at −20°C. Serial dilutions were prepared in culture medium in order to obtain non-cytotoxic concentrations of organic solvents and antibiotics, and allowing the addition of a similar volume of vehicle in all experiments.
Determination of non-cytotoxic concentrations of the organic solvents
In this formula a = OD450nm derived from the wells incubated with solvent, b = OD450nm derived from blank wells, c = OD450nm derived from untreated control wells.
Assessment of cytotoxicity after exposure of IPEC-J2 cells to the investigated antibiotics doxycycline and paromomycin
A flow cytometric technique was used to assess the direct cytotoxic effect of the antibiotics doxycycline and paromomycin. IPEC-J2 cells were seeded at a concentration of 5 × 105 cells/ml in 24-well plates in 1 ml of culture medium and allowed to grow for 24 h. Next, cells were treated for 24 h with 0, 5, 10, 20 and 40 μg/ml of doxycycline or paromomycin. Each experiment was conducted in triplicate. After the incubation period, cells were trypsinized, culture medium and cells were collected, centrifuged for 5 min at 524 × g and 4°C and resuspended in 0.5 ml Hank’s Buffered Salt Solution (HBSS, Gibco). This procedure was repeated three times in order to remove cellular debris and antibiotics. Cell death was assessed using dual staining with Annexin-V-fluorescein isothiocyanate (Annexin-V-FITC, Roche Diagnostics, Belgium) and propidium iodide (PI, Sigma-Aldrich) which allows the discrimination of viable cells (FITC-/PI-), apoptotic (FITC+/PI-) and necrotic cells (FITC+/PI+). Cells were incubated for 20 min in the dark on ice with 100 μl of a solution containing 20 μl Annexin-V-FITC and 20 μl PI dissolved in 1000 μl incubation buffer containing 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 140 mM NaCl and 5 mM CaCl2. Cells were assessed by a FACSCanto flow cytometer (Becton, Dickinson and Company, Erembodegem, Belgium) and the percentage of viable, apoptotic and necrotic cells was obtained using the FACSDiva Software (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).
Assessment of cytotoxicity after exposure of IPEC-J2 cells to Fusariumtoxins
The flow cytometric technique as described above was also used to assess the direct cytotoxic effect of mycotoxins. IPEC-J2 cells were seeded at a concentration of 5 × 105 cells/ml in 24-well plates in 1 ml of culture medium and allowed to grow for 24 h. Next, cells were treated for 72 h with increasing concentrations of T-2 (0–10 ng/ml), DON (0–10 μg/ml), ZEA (0–20 μg/ml) and FB1 (0–15 μg/ml). The molar concentration corresponding with 1 μg/ml DON, FB1 and ZEA and 1 ng/ml T-2 is 3.37 μM, 1.39 μM, 3.14 μM and 2.14 nM, respectively. Each experiment was conducted in triplicate. After the incubation period, cells were processed as described above before analysis on the FACSCanto flow cytometer. The concentration corresponding to 50% reduction in viable cells (IC50) was calculated with linear regression curves. A positive control was provided by cells single stained with Annexin-V-FITC and cells single stained with PI, also used to determine spectral overlap, after treatment for 72 h with 10 μg/ml DON. Furthermore, unstained cells (no Annexin-V-FITC and no PI) were also included to determine autofluorescence of IPEC-J2 cells.
Assessment of TEER after exposure of IPEC-J2 cells to DON and T-2
The effect of DON and T-2 on barrier integrity was determined by measuring the transepithelial electrical resistance (TEER) using a Millicell Electrical Resistance System (Millipore, World Precision Instruments, Sarasota, FL, USA). Cells were grown and differentiated on Transwell® collagen-coated polytetrafluoroethylene (PFTE) membrane inserts (0.4 μm pore diameter, 6.5 mm diameter, Corning Inc., NY, USA) at a density of 1.5 × 105 cells/ml. Culture medium was replaced three times a week and IPEC-J2 cells were used for TEER experiments at day 21 post-seeding. Next, cells were incubated for 72 h with different concentrations of T-2 (0–100 ng/ml) or DON (0–10 μg/ml). TEER was measured every 24 h from the start of the toxin exposure until 3 days. TEER values were expressed as kΩ × cm2. Each single experiment was conducted in threefold.
Passage of doxycycline and paromomycin after exposure of IPEC-J2 cells to DON and T-2
Cells were seeded on Transwell® collagen-coated PFTE membrane inserts as described above for the TEER experiment. Only cells which are cultured for 21 days show stable TEER values indicating cells have reached confluence and form a tight monolayer (data not shown). Next, cells were incubated for 72 h with different concentrations of T-2 (0–100 ng/ml) or DON (0–10 μg/ml), during which the last 24 h a non-cytotoxic concentration of both paromomycin (30 μg/ml) and doxycycline (10 μg/ml) was added to the apical (AP) compartment of the transwell. To evaluate the permeability of the monolayers, 50 μl of transport medium was withdrawn from the basolateral (BL) compartment at time 0 (before) and at 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 h after addition of the drugs and replaced immediately by 50 μl of fresh culture medium. Each experiment was conducted in triplicate.
Acceptor media were analyzed for the paromomycin content by high-performance liquid chromatography tandem mass spectrometry (LC-MS/MS). The LC-MS/MS system consisted of a Surveyor Autosampler Plus and MS Pump Plus, coupled to a TSQ Quantum Ultra® triple quadrupole mass spectrometer (all from ThermoFisher Scientific, Zellik, Belgium). Chromatographic separation was performed on a PLRP-S column (150 mm x 2.1 mm i.d., 100 Å, dp: 5 μm, Varian, Middelburg, The Netherlands) using a gradient programme (flow-rate: 200 μl/min). The mobile phase consisted of (A) 20 mM pentafluoropropionic acid (PFPA) (Sigma-Aldrich) in water and (B) 20 mM PFPA in water/acetonitrile (50/50, v/v) (VWR International, Leuven, Belgium). The MS instrument was operated in the selected reaction monitoring (SRM) mode, using two precursor ion > product ion transitions. Tobramycin (Sigma-Aldrich) was used as internal standard (IS). Samples were prepared by pipetting 50 μl culture medium into an Eppendorf cup (Novolab, Geraardsbergen, Belgium). Each sample was spiked with 10 μl of the IS working solution of 1 μg/ml in HPLC grade water (VWR International) and diluted with 65 μl methanol, 100 μl HPLC grade water and 25 μl 200 mM PFPA. After vortexing, samples were centrifuged at 7 800 × g for 10 min to remove possible solid particles. The sample was transferred into screw-capped conical vials and 5 μl were injected onto the LC-MS/MS system.
Doxycycline concentrations were determined using the same LC-MS/MS configuration and HPLC column as for paromomycin analysis. The mobile phase consisted of (A) 0.5% acetic acid in water and (B) acetonitrile. A gradient programme was applied and the flow-rate was 200 μl/min. The MS instrument was operated in the SRM mode, using two precursor ion > product ion transitions. Demethylchlortetracycline (DMCTC, Sigma-Aldrich) was used as IS. Samples were prepared by pipetting 25 μl culture medium into an Eppendorf cup. Each sample was spiked with 12.5 μl of the IS working solution of 10 μg/ml in HPLC grade water, followed by the addition of 75 μl 0.5% formic acid in HPLC grade water. After vortexing briefly and centrifugation, 5 μl were injected onto the LC-MS/MS system.
The limit of quantification (LOQ) was 10 ng/ml for both doxycycline and paromomycin. A detailed description of both methods can be found in Goossens et al. .
Data were analyzed using one-way analysis of variance (ANOVA) to address the significance of difference between mean values with significance set at P < 0.05.
A concentration of 1% ethanol, 5% methanol or 5% acetonitrile of the total volume of culture medium was determined to be non-cytotoxic for IPEC-J2 cells
A final concentration of 5% acetonitrile, 5% methanol and 1% ethanol was accepted to use in the experiment as the viability of IPEC-J2 cells was on average > 95%. Non-cytotoxic concentrations of the solvents were ensured by appropriate dilution of the toxins stock solutions in culture medium.
A concentration of 10 μg/ml doxycycline and 30 μg/ml paromomycin was determined to be non-cytotoxic for IPEC-J2 cells
A concentration up to 40 μg/ml doxycycline or paromomycin caused no significant reduction in cell viability of IPEC-J2 cells. It was concluded that a concentration of 10 μg/ml doxycycline and 30 μg/ml paromomycin could be used in the experiments. The concentration of the antibiotics was based on, on the one hand, the dose of the antibiotic that is usually administered to pigs, and on the other hand, the capacity of the intestine of an adult pig. When 10 mg/kg body weight doxycycline and 40 mg/kg body weight paromomycin is administered to a pig of 20 kg, and this dose ends up in an intestinal volume of 27.5 l, this corresponds with a concentration of about 8 and 29 μg/ml respectively.
Induction of necrosis and apoptosis in IPEC-J2 cells is Fusariumtoxin dependent
Exposure of IPEC-J2 cells for 72 h to different mycotoxin concentrations showed a concentration-dependent toxicity. T-2 was clearly the most toxic one with a significantly lower percentage of Annexin-V-FITC and PI negative cells in the ng/ml range compared to DON and ZEA which were toxic in the μg/ml range.
FB1 was not toxic at the tested concentrations. For all mycotoxins, except T-2 toxin, a higher percentage of Annexin-V-FITC positive and PI negative cells rather than Annexin-V-FITC and PI positive cells can be found after exposure of undifferentiated IPEC-J2 cells for 72 h to different toxin concentrations. For T-2 toxin, the majority of dead cells were Annexin-V-FITC and PI positive. The IC50 for DON and T-2 was determined to be 6.98 μg/ml and 9.55 ng/ml, respectively.
Cytotoxic concentrations of DON and T-2 induce a decrease in transepithelial electrical resistance (TEER) across the IPEC-J2 monolayer
Both for T-2 and DON, a drop in TEER can be seen 24 h after incubation of IPEC-J2 cells with cytotoxic concentrations of the mycotoxins. Treatment with non-cytotoxic concentrations results in TEER values comparable to those of the control cells. Treatment of differentiated IPEC-J2 cells with 1 μg/ml DON shows a time-dependent decline in TEER.
Disruption of epithelial integrity of the IPEC-J2 cell monolayer results in increased passage of doxycycline and paromomycin
In both the T-2 and DON experiment, increased passage of doxycycline and paromomycin was seen after incubation of IPEC-J2 cells with cytotoxic concentrations of the tested mycotoxins.
The gastrointestinal tract can be exposed to high concentrations of mycotoxins after ingestion of mycotoxin contaminated food or feed. Since swine are the most sensitive domestic animal species to mycotoxins , this study aimed to investigate the toxic effect of four common Fusarium toxins, T-2, DON, ZEA and FB1 on IPEC-J2 cells. Studies concerning the effects of mycotoxins on IPEC-J2 cells are limited. The concentrations of the mycotoxins tested in this study are the result of several optimization experiments performed to refine the concentration range to be used for these in vitro experiments. According to Sergent et al. DON concentrations in human intestine are estimated between 0.16 μg/ml and 2 μg/ml depending on the contamination level of the feed, including thus our tested range. Mycotoxin concentrations in the test solutions are not based on levels known to cause problems in pigs, but are based on the cytotoxicity results of the flow cytometer experiments, the solubility of the mycotoxin in aqueous solvents, and cost of the mycotoxin.
In vitro cell viability assays have a central role in predictive toxicology. The capability of commonly used colorimetric assays, such as the WST-1, MTT (3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazolium bromide) and MTS assay (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) or the lactate dehydrogenase (LDH) bioassay to detect cytotoxic effects is, however, limited. Cells that are apoptotic remain undetected with these assays. Our study used a flow cytometric technique, which allows to distinguish Annexin-V-FITC and PI negative (viable) cells from Annexin-V-FITC positive and PI negative (apoptotic) cells and Annexin-V-FITC and PI positive (necrotic) cells.
After 72 h of exposure with T-2, DON, FB1 or ZEA, T-2 clearly was the most cytotoxic with a toxicity in the ng/ml range, while the other mycotoxins are only toxic at concentrations in the μg/ml range. This finding is in accordance with the study of Calvert et al. , who demonstrated that T-2 was most cytotoxic against three human cell lines tested as determined by the MTT assay.
When comparing the percentage Annexin-V-FITC positive and PI negative cells and Annexin-V-FITC and PI positive cells, it is striking that more Annexin-V-FITC and PI positive cells than Annexin-V-FITC positive and PI negative cells were found after treatment of the cells with T-2. This corresponds, however, with findings in practice where T-2, present in feed, causes skin necrosis [25, 26]. Also necrosis of the lymphoid cells of the intestinal mucosa was seen after intake of T-2 contaminated feed [25, 27]. DON, on the other hand, causes more Annexin-V-FITC positive and PI negative cells than Annexin-V-FITC and PI positive cells. The discrepancy between type A (T-2) and type B (DON) trichothecenes was also demonstrated by Nasri et al.  who showed that DON causes rather apoptosis and T-2 rather necrosis in Jurkat T-lymphocytes. As it is known that type B trichothecenes activate the MAPK signaling pathway resulting in apoptosis, while type A trichothecenes are not able to activate the MAPK families [29–31], the authors suggested this as an explanation for the results. For ZEA and FB1, although FB1 was not cytotoxic at the tested concentrations, an approximately equal percentage of apoptotic and necrotic cells were seen after treatment of IPEC-J2 cells for 72 h with those toxins. Our results suggest that different toxins may induce different types of cell death in IPEC-J2 cells. To our knowledge, this is the first report of DON and T-2 induced different mechanisms of cell death in IPEC-J2 cells. Since it was not the principal aim of this study to elaborate further the differences in the mode of cell death induced by different mycotoxins, no further experiments were conducted. Nevertheless, it could be interesting to investigate these differences in more detail, including the investigation of associated pathway molecules, the analysis of potential protective effects of caspase inhibitors and/or necrose inhibitors, etc. Also other types of cell death can be taken into account since there are more than two ways for a cell to die. Cell death can be classified according to its morphological appearance (apoptotic, necrotic, autophagic or associated with mitosis), enzymological criteria (with and without the involvement of nucleases or distinct classes of proteases, such as caspases, calpains, cathepsins and transglutaminases), functional aspects (programmed or accidental, physiological or pathological) or immunological characteristics (immunogenic or non-immunogenic) . It could be interesting exploring these differences in relation with mycotoxins.
Correlatively with direct cytotoxicity, the consequences on barrier integrity (TEER and passage of drugs) were also assessed. The effect on TEER and passage was only studied for DON and T-2 because, of the four mycotoxins tested in this study, these are the most toxic ones and their ratio of Annexin-V-FITC positive and PI negative cells and Annexin-V-FITC and PI positive cells is antithetic. Notwithstanding the assertion of Geens and Niewold  that IPEC-J2 cells cultured on Transwell®-collagen coated inserts with a surface area of 0.33 cm2 are not appropriate to measure TEER values, our IPEC-J2 monolayer showed TEER values above 10 kΩ cm2 after 3 weeks of culturing. According to Fromter and Diamond , IPEC-J2 cell lines with TEER values of approximately 2 kΩ cm2 can be considered to be tight epithelia. When IPEC-J2 cells were incubated with cytotoxic concentrations of DON (5 and 10 μg/ml) and T-2 (10 and 100 ng/ml) TEER values dropped to nearly 0 kΩ cm2 after 24 h suggesting a complete disruption of the epithelial monolayer within 24 h. In contrast, TEER values of IPEC-J2 cells incubated with non-toxic concentrations (0.5 μg/ml DON and 0.1 and 1 ng/ml T-2) were comparable to the TEER of control cells. Treatment with 1 μg/ml DON on the other hand shows a time-dependent reduction of the TEER. This was also reported by Pinton et al.  who showed a time- and dose-dependent reduction of the TEER after exposure of IPEC-1 and Caco-2 cells to different concentrations (0, 3, 6, 15, 30 μg/ml) of DON. A decreased barrier function in vitro is reflected in both a decreased TEER and an increased tracer flux [17, 35]. In our study, the decrease in TEER is related to the passage of the used tracers, doxycycline (molecular weight (mw) 513 Da) and paromomycin (mw 714 Da), two commonly used antibiotics in pig industry. The higher the toxin concentration, the higher the marker passage. Most studies use tracers such as FITC-dextran, while in this study and for the first time the antibiotics doxycycline and paromomycin were used as markers. We were, however, not capable of demonstrating that induction of more apoptosis or more necrosis results in differences in transepithelial passage of antibiotics. Both doxycycline and paromomycin pass the epithelial monolayer, regardless the induction of a different cell death mechanism.
It is very interesting to study the passage of these therapeutic compounds during in vivo trials, as veterinary drugs are often used in pig mass medication and frequently administered by the oral route, i.e. mixed in the feed or drinking water.
When discussing the relevance of the in vitro results for the in vivo situation it needs to be taken into account that enterocytes are not continuously exposed to mycotoxins. Rather a time-dependent fluctuation in mycotoxin concentrations exists in vivo, whereas in vitro cells are exposed continuously at constant concentrations. Nevertheless, the current in vitro findings warrant further investigation in vivo because an increased passage of antibiotics may have important implications for both animal and human health. Increased absorption of antibiotics may lead to higher plasma levels, including the risk of exceeding the toxic threshold. Moreover, increased antibiotic plasma levels may also lead to a tissue residue problem in slaughter animals and inherent food safety concerns. It could thus be interesting to investigate in vivo the effect of mycotoxins on the intestinal absorption of antibiotics.
This work was supported by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen), Brussels, Belgium (N° 070574). The excellent assistance of A. Van den Bussche, K. Demeyere and K. De Koninckx during the experiments is gratefully appreciated.
- Council for Agricultural Science and Technology (CAST): Mycotoxins: Risks in Plant Animal and Human Systems. Task Force Report No. 139. Ames, Iowa, USA; 2003.Google Scholar
- Nelson PE, Dignani MC, Anaissie EJ: Taxonomy, biology and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994, 7: 479-504.PubMed CentralPubMedGoogle Scholar
- D'Mello JPF, Placinta CM, Macdonald AMC: Fusarium mycotoxins: a review of global implications for animal health, welfare and productivity. Anim Feed Sci Tech. 1999, 80: 183-205. 10.1016/S0377-8401(99)00059-0.View ArticleGoogle Scholar
- Gutleb AC, Morrison E, Murk AJ: Cytotoxicity assays for mycotoxins produced by Fusarium strains: a review. Environ Toxicol Pharmacol. 2002, 11: 309-320. 10.1016/S1382-6689(02)00020-0.View ArticlePubMedGoogle Scholar
- Caloni F, Spotti M, Pompa G, Zucco F, Stammati A, De Angelis I: Evaluation of fumonisin B(1) and its metabolites absorption and toxicity on intestinal cells line Caco-2. Toxicon. 2002, 40: 1181-1188. 10.1016/S0041-0101(02)00125-3.View ArticlePubMedGoogle Scholar
- Caloni F, Stammati AL, Raimondi F, De Angelis I: In vitro study with Caco-2 cells on fumonisin B1: aminopentol intestinal passage and role of P-glycoprotein. Vet Res Commun. 2005, 29: 285-287. 10.1007/s11259-005-0063-8.View ArticlePubMedGoogle Scholar
- Calvert TW, Aidoo KE, Candlish AG, Fuat AR: Comparison of in vitro cytotoxicity of Fusarium mycotoxins, deoxynivalenol, T-2 toxin and zearalenone on selected human epithelial cell lines. Mycopathologia. 2005, 159: 413-419. 10.1007/s11046-005-0254-4.View ArticlePubMedGoogle Scholar
- De Angelis I, Friggè G, Raimondi F, Stammati A, Zucco F, Caloni F: Absorption of fumonisin B1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon. 2005, 45: 285-291. 10.1016/j.toxicon.2004.10.015.View ArticlePubMedGoogle Scholar
- Kasuga F, Hara-Kudo Y, Saito N, Kumagai S, Sugita-Konishi Y: In vitro effect of deoxynivalenol on the differentiation of human colonic cell lines Caco-2 and T84. Mycopathologia. 1998, 142: 161-167. 10.1023/A:1006923808748.View ArticlePubMedGoogle Scholar
- Kouadio JH, Mobio TA, Baudrimont I, Moukha S, Dano SD, Creppy EE: Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology. 2005, 213: 56-65. 10.1016/j.tox.2005.05.010.View ArticlePubMedGoogle Scholar
- Maresca M, Yahi N, Younès-Sakr L, Boyron M, Caporiccio B, Fantini J: Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol. 2008, 228: 84-92. 10.1016/j.taap.2007.11.013.View ArticlePubMedGoogle Scholar
- Pinton P, Nougayrède JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, Bracarense AP, Kolf-Clauw M, Oswald IP: The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol. 2009, 237: 41-48. 10.1016/j.taap.2009.03.003.View ArticlePubMedGoogle Scholar
- Pinton P, Braicu C, Nougayrede JP, Laffitte J, Taranu I, Oswald IP: Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism. J Nutr. 2010, 140: 1956-1962. 10.3945/jn.110.123919.View ArticlePubMedGoogle Scholar
- Sergent T, Parys M, Garsou S, Pussemier L, Schneider YJ, Larondelle Y: Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol Lett. 2006, 164: 167-176. 10.1016/j.toxlet.2005.12.006.View ArticlePubMedGoogle Scholar
- Van de Walle JV, Sergent T, Piront N, Toussaint O, Schneider YJ, Larondelle Y: Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis. Toxicol Appl Pharmacol. 2010, 245: 291-298. 10.1016/j.taap.2010.03.012.View ArticleGoogle Scholar
- Videmann B, Mazallon M, Tep J, Lecoeur S: Metabolism and transfer of the mycotoxin zearalenone in human intestinal Caco-2 cells. Food Chem Toxicol. 2008, 46: 3279-3286. 10.1016/j.fct.2008.07.011.View ArticlePubMedGoogle Scholar
- Bouhet S, Hourcade E, Loiseau N, Fikry A, Martinez S, Roselli M, Galtier P, Mengheri E, Oswald IP: The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol Sci. 2004, 77: 165-171.View ArticlePubMedGoogle Scholar
- Awad WA, Aschenbach JR, Zentek J: Cytotoxicity and metabolic stress induced by deoxynivalenol in the porcine intestinal IPEC-J2 cell line. J Anim Physiol Anim Nutr. 2011, 96: 717-724.Google Scholar
- Diesing AK, Nossol C, Dänicke S, Walk N, Post A, Kahlert S, Rothkötter HJ, Kleuss J: Vulnerability of polarized intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application. PLoS One. 2011, 6: e17472-10.1371/journal.pone.0017472.PubMed CentralView ArticlePubMedGoogle Scholar
- Diesing A, Nossol C, Panther P, Walk N, Post A, Kluess J, Kreutzmann P, Dänicke S, Rothkötter H, Kahlert S: Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2. Toxicol Lett. 2011, 200: 8-18. 10.1016/j.toxlet.2010.10.006.View ArticlePubMedGoogle Scholar
- Loiseau N, Debrauwer L, Sambou T, Bouhet S, Miller JD, Martin PG, Viadère JL, Pinton P, Puel O, Pineau T, Tulliez J, Galtier P, Oswald IP: Fumonisin B1 exposure and its selective effect on porcine jejunal segment: sphingolipids, glycolipids and trans-epithelial passage disturbance. Biochem Pharmacol. 2007, 74: 144-152. 10.1016/j.bcp.2007.03.031.View ArticlePubMedGoogle Scholar
- Schierack P, Nordhoff M, Pollmann M, Weyrauch KD, Amasheh S, Lodemann U, Jores J, Tachu B, Kleta S, Blikslager A, Tedin K, Wieler LH: Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochem Cell Biol. 2006, 125: 293-305. 10.1007/s00418-005-0067-z.View ArticlePubMedGoogle Scholar
- Goossens J, Vandenbroucke V, Pasmans F, De Baere S, Devreese M, Osselaere A, Verbrugghe E, Haesebrouck F, De Saeger S, Eeckhout M, Audenaert K, Haesaert G, De Backer P, Croubels S: Influence of mycotoxins and a mycotoxin adsorbing agent on the oral bioavailability of commonly used antibiotics in pigs. Toxins. 2012, 4: 281-295. 10.3390/toxins4040281.PubMed CentralView ArticlePubMedGoogle Scholar
- Hussein HS, Brasel JM: Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology. 2001, 167: 101-134. 10.1016/S0300-483X(01)00471-1.View ArticlePubMedGoogle Scholar
- Harvey RB, Kubena LF, Corrier DE, Huff WE, Rottinghaus GE: Cutaneous ulceration and necrosis in pigs fed aflatoxin- and T-2 toxin-contaminated diets. J Vet Diagn Invest. 1990, 2: 227-229. 10.1177/104063879000200314.View ArticlePubMedGoogle Scholar
- Pang VF, Swanson SP, Beasley VR, Buck WB, Haschek WM: The toxicity of T-2 toxin in swine following topical application. I. Clinical signs, pathology, and residue concentrations. Fundam Appl Toxicol. 1987, 9: 41-49. 10.1016/0272-0590(87)90152-7.View ArticlePubMedGoogle Scholar
- Fekete S, Tamas J, Vanyi A, Glavits R, Bata A: Effect of T-2 toxin on feed intake, digestion and pathology of rabbits. Lab Anim Sci. 1989, 39: 603-606.PubMedGoogle Scholar
- Nasri T, Bosch R, Voorde S, Fink-Gremmels J: Differential induction of apoptosis by type A and B trichothecenes in Jurkat T-lymphocytes. Toxicol In Vitro. 2006, 20: 832-840. 10.1016/j.tiv.2006.01.003.View ArticlePubMedGoogle Scholar
- Moon Y, Uzarski R, Pestka J: Relationship of trichothecene structure to COX-2 induction in the macrophage: selective action of type B (8-keto) trichothecenes. J Toxicol Environ Health A. 2003, 66: 1967-1983. 10.1080/713853950.View ArticlePubMedGoogle Scholar
- Shifrin V, Anderson P: Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 1999, 274: 13985-13992. 10.1074/jbc.274.20.13985.View ArticlePubMedGoogle Scholar
- Zhou H, Jia Q, Pestka J: Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. Toxicol Sci. 2005, 85: 916-926. 10.1093/toxsci/kfi146.View ArticlePubMedGoogle Scholar
- Melino G: The sirens’ song. Nature. 2001, 412: 23-10.1038/35083653.View ArticlePubMedGoogle Scholar
- Geens MM, Niewold TA: Optimizing culture conditions of a porcine epithelial cell line IPEC-J2 through a histological and physiological characterization. Cytotechnology. 2011, 63: 415-423. 10.1007/s10616-011-9362-9.PubMed CentralView ArticlePubMedGoogle Scholar
- Fromter E, Diamond J: Route of passive ion permeation in epithelia. Nat New Biol. 1972, 235: 9-13.View ArticlePubMedGoogle Scholar
- Mahfoud R, Maresca M, Garmy N, Fantini J: The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol Appl Pharmacol. 2002, 181: 209-218. 10.1006/taap.2002.9417.View ArticlePubMedGoogle Scholar